NDC 0074-3093

Viekira Pak

Dasabuvir And Ombitasvir And Paritaprevir And Ritonavir

Viekira Pak is a Kit in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is .

Product ID0074-3093_72523e58-d587-39a6-7c7b-ca6daccb8f69
NDC0074-3093
Product TypeHuman Prescription Drug
Proprietary NameViekira Pak
Generic NameDasabuvir And Ombitasvir And Paritaprevir And Ritonavir
Dosage FormKit
Marketing Start Date2014-12-19
Marketing CategoryNDA / NDA
Application NumberNDA206619
Labeler NameAbbVie Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0074-3093-01

1 DOSE PACK in 1 CARTON (0074-3093-01) > 1 KIT in 1 DOSE PACK
Marketing Start Date2014-12-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0074-3093-28 [00074309328]

Viekira Pak KIT
Marketing CategoryNDA
Application NumberNDA206619
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-12-19

NDC 0074-3093-01 [00074309301]

Viekira Pak KIT
Marketing CategoryNDA
Application NumberNDA206619
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-12-19

Drug Details

OpenFDA Data

SPL SET ID:ab74e474-9fd6-902c-9bd9-16dc9541edd0
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 1597386
  • 1597387
  • 1597379
  • 1597388
  • NDC Crossover Matching brand name "Viekira Pak" or generic name "Dasabuvir And Ombitasvir And Paritaprevir And Ritonavir"

    NDCBrand NameGeneric Name
    0074-3093Viekira PakDasabuvir and Ombitasvir and Paritaprevir and Ritonavir
    0074-0063ViekiraDasabuvir and Ombitasvir and Paritaprevir and Ritonavir

    Trademark Results [Viekira Pak]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VIEKIRA PAK
    VIEKIRA PAK
    86425792 4788976 Live/Registered
    AbbVie Inc.
    2014-10-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.